GSK3B and metastatic malignant neoplasm in the lymph nodes: Loss of SARI and E-cadherin and increased vimentin, p-GSK-3β, and β-catenin levels were clearly detected in tissues from lung adenocarcinoma patients with lymph node metastasis (Fig. 6C).